Keros Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22%.

Top 25 shareholders own 78.89% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.3%	Pontifax Venture Capital	4,787,331	US$258.5m	0%	91.17%
10.7%	FMR LLC	3,874,204	US$209.2m	7.47%	0.01%
6%	BlackRock, Inc.	2,166,010	US$117.0m	6.34%	no data
4.28%	The Vanguard Group, Inc.	1,545,758	US$83.5m	7.93%	no data
3.8%	Arkin Bio Venture Partners Ltd.	1,371,074	US$74.0m	0%	87.8%
3.52%	OrbiMed Advisors LLC	1,268,734	US$68.5m	-16.2%	0.93%
3.48%	Alkeon Capital Management, LLC	1,256,421	US$67.8m	-12.4%	0.52%
3.1%	Braidwell LP	1,118,961	US$60.4m	-17.6%	4.45%
2.94%	Darwin Global Management Limited	1,060,427	US$57.3m	0%	22.65%
2.92%	State Street Global Advisors, Inc.	1,054,367	US$56.9m	16.9%	no data
2.89%	T. Rowe Price Group, Inc.	1,041,701	US$56.3m	-17.8%	0.01%
2.56%	Morgan Stanley, Investment Banking and Brokerage Investments	922,046	US$49.8m	107%	0.01%
2.11%	Citadel Advisors LLC	760,168	US$41.0m	87.6%	0.04%
1.94%	Franklin Resources, Inc.	699,411	US$37.8m	48%	0.01%
1.91%	ADAR1 Capital Management, LLC	688,316	US$37.2m	0%	15.18%
1.81%	Candriam	651,999	US$35.2m	-20.4%	0.1%
1.62%	Woodline Partners LP	583,792	US$31.5m	-18.7%	0.35%
1.61%	Eventide Asset Management, LLC	580,000	US$31.3m	0%	0.53%
1.59%	Mass General Brigham Ventures, LLC	574,301	US$31.0m	0%	38.97%
1.45%	Millennium Management LLC	522,128	US$28.2m	156%	0.02%
1.41%	Geode Capital Management, LLC	510,211	US$27.6m	4.98%	no data
1%	Parkman Healthcare Partners LLC	360,467	US$19.5m	20.8%	2.61%
0.99%	Deutsche Asset & Wealth Management	358,276	US$19.3m	2,750%	0.01%
0.99%	Opaleye Management Inc.	357,500	US$19.3m	-0.8%	4.74%
0.98%	CHI Advisors LLC	352,633	US$19.0m	-13.5%	6.3%